The original RNA-seq results suggested that glioma patients have higher levels of CCL20, CXCL1, CXCL2, CXCL5, and CXCL16 compared to noncancerous patients and that the levels of these small chemotactic cytokines in glioma are correlated with malignancy. The gene discussed is CXCL16; the disease is glioma.